Abd Elmaaboud MA, Estfanous RS, Atef A et al (2023) Dapagliflozin/hesperidin combination mitigates lipopolysaccharide-induced Alzheimer’s disease in rats. Pharmaceuticals 16:1370. https://doi.org/10.3390/ph16101370

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdelsalam RM, Hamam HW, Eissa NM et al (2025) Empagliflozin dampens doxorubicin-induced chemobrain in rats: the possible involvement of oxidative stress and PI3K/Akt/mTOR/NF-κB/TNF-α signaling pathways. Mol Neurobiol 62:3480–3492. https://doi.org/10.1007/s12035-024-04499-5

Article  CAS  PubMed  Google Scholar 

Aksoz E, Gocmez SS, Sahin TD et al (2019) The protective effect of metformin in scopolamine-induced learning and memory impairment in rats. Pharmacol Rep 71:818–825. https://doi.org/10.1016/j.pharep.2019.04.015

Article  CAS  PubMed  Google Scholar 

Ali AA, I Ahmed H (2016) The potential effect of caffeine and nicotine co-administration against aluminum-induced Alzheimer’s disease in Rats. J Alzheimers Dis Parkinsonism https://doi.org/10.4172/2161-0460.1000236

Amer RM, Eltokhy AK, Elesawy RO et al (2022) The ameliorative effect of empagliflozin in vigabatrin-induced cerebellar/neurobehavioral deficits: targeting mTOR/AMPK/SIRT-1 signaling pathways. Molecules 27:3659. https://doi.org/10.3390/molecules27123659

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amidfar M, Réus GZ, Quevedo J et al (2017) Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain. Brain Res Bull 128:29–33. https://doi.org/10.1016/j.brainresbull.2016.11.003

Article  CAS  PubMed  Google Scholar 

An J, Haile WB, Wu F et al (2014) Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system. Neuroscience 257:41–48. https://doi.org/10.1016/j.neuroscience.2013.10.060

Article  CAS  PubMed  Google Scholar 

An Y, Varma VR, Varma S et al (2018) Evidence for brain glucose dysregulation in Alzheimer’s disease. Alzheim Dementia 14:318–329. https://doi.org/10.1016/j.jalz.2017.09.011

Article  Google Scholar 

Anoush M, Taghaddosi N, Bokaei Hosseini Z et al (2025) Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats. IBRO Neurosci Rep 18:163–170. https://doi.org/10.1016/j.ibneur.2025.01.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13:93–110. https://doi.org/10.1007/s10339-011-0430-z

Article  CAS  PubMed  Google Scholar 

Arab HH, Safar MM, Shahin NN (2021) Targeting ROS-dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 pathways by Dapagliflozin attenuates neuronal injury and motor dysfunction in rotenone-induced parkinson’s disease rat model. ACS Chem Neurosci 12:689–703. https://doi.org/10.1021/acschemneuro.0c00722

Article  CAS  PubMed  Google Scholar 

Araujo JA, Zhang M, Yin F (2012) Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis. Front Pharmacol https://doi.org/10.3389/fphar.2012.00119

Ashok A, Rai NK (2023) Metal mixture-induced non-transgenic animal model of Alzheimer’s disease: Pros Cons Pre-Clinical Res https://doi.org/10.4081/pcr.2023.7768

Ashok A, Rai NK, Tripathi S, Bandyopadhyay S (2015) Exposure to As-, Cd-, and Pb-mixture induces Aβ, Amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol Sci 143:64–80. https://doi.org/10.1093/toxsci/kfu208

Article  CAS  PubMed  Google Scholar 

Assefa BT, Tafere GG, Wondafrash DZ, Gidey MT (2020) The bewildering effect of AMPK activators in Alzheimer’s disease: review of the current evidence. Biomed Res Int https://doi.org/10.1155/2020/9895121

Assi A-A, Abdelnabi S, Attaai A, Abd-ellatief RB (2022) Effect of ivabradine on cognitive functions of rats with scopolamine-induced dementia. Sci Rep 12:16970. https://doi.org/10.1038/s41598-022-20963-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Assi A-A, Farrag MMY, Badary DM et al (2023) Protective effects of curcumin and Ginkgo biloba extract combination on a new model of Alzheimer’s disease. Inflammopharmacology 31:1449–1464. https://doi.org/10.1007/s10787-023-01164-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balmik AA, Chinnathambi S (2021) Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease. Cell Commun Signal 19:51. https://doi.org/10.1186/s12964-021-00732-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barichello T, dos Santos I, Savi GD et al (2010) TNF-α, IL-1β, IL-6, and cinc-1 levels in rat brain after meningitis induced by Streptococcus pneumoniae. J Neuroimmunol 221:42–45. https://doi.org/10.1016/j.jneuroim.2010.02.009

Article  CAS  PubMed  Google Scholar 

Borikar SP, Sonawane DS, Tapre DN, Jain SP (2024) Exploring the neuropharmacological potential of empagliflozin on nootropic and scopolamine-induced amnesic model of Alzheimer’s like conditions in rats. Int J Neurosci https://doi.org/10.1080/00207454.2024.2342973

Bortolussi G, Shi X, ten Bloemendaal L et al (2021) Long-term effects of Biliverdin reductase a deficiency in Ugt1−/−mice: impact on redox status and metabolism. Antioxidants 10:2029. https://doi.org/10.3390/antiox10122029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai Z, Yan L-J, Li K et al (2012) Roles of AMP-activated protein kinase in Alzheimer’s disease. Neuromolecular Med 14:1–14. https://doi.org/10.1007/s12017-012-8173-2

Article  CAS  PubMed  Google Scholar 

Cai Z, Zhou Y, Xiao M, et al (2015) Activation of mTOR: a culprit of Alzheimer’s disease? Neuropsychiatr Dis Treat 1015. https://doi.org/10.2147/NDT.S75717

Canesin G, Hejazi SM, Swanson KD, Wegiel B (2020) Heme-derived metabolic signals dictate immune responses. Front Immunol https://doi.org/10.3389/fimmu.2020.00066

Chen H, Tran D, Yang H-C et al (2020) Dapagliflozin and ticagrelor have additive effects on the attenuation of the activation of the NLRP3 inflammasome and the progression of diabetic cardiomyopathy: an AMPK–mTOR Interplay. Cardiovasc Drugs Ther 34:443–461. https://doi.org/10.1007/s10557-020-06978-y

Article  CAS  PubMed  Google Scholar 

Chopra I, Li HF, Wang H, Webster KA (2012) Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia 55:783–794. https://doi.org/10.1007/s00125-011-2407-y

Article  CAS  PubMed  Google Scholar 

Cole SL, Vassar R (2007) The Alzheimer’s disease Beta-secretase enzyme, BACE1. Mol Neurodegener 2:22. https://doi.org/10.1186/1750-1326-2-22

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coman H, Nemeş B (2017) New therapeutic targets in Alzheimer’s disease. Int J Gerontol 11:2–6. https://doi.org/10.1016/j.ijge.2016.07.003

Article  Google Scholar 

Dalle Pezze P, Ruf S, Sonntag AG et al (2016) A systems study reveals concurrent activation of AMPK and mTOR by amino acids. Nat Commun 7:13254. https://doi.org/10.1038/ncomms13254

Article  CAS  PubMed  Google Scholar 

Delgoffe GM, Kole TP, Zheng Y et al (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30:832–844. https://doi.org/10.1016/j.immuni.2009.04.014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dengler F (2020) Activation of AMPK under hypoxia: many roads leading to rome. Int J Mol Sci 21:2428. https://doi.org/10.3390/ijms21072428

Article  CAS  PubMed  PubMed Central  Google Scholar 

Do TD, Economou NJ, Chamas A et al (2014) Interactions between amyloid-β and tau fragments promote aberrant aggregates: implications for amyloid toxicity. J Phys Chem B 118:11220–11230. https://doi.org/10.1021/jp506258g

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong H, Yuede CM, Coughlan CA et al (2009) Effects of donepezil on amyloid-β and synapse density in the Tg2576 mouse model of Alzheimer’s disease. Brain Res 1303:169–178. https://doi.org/10.1016/j.brainres.2009.09.097